Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest
Display:
?
Drug:  lurbinectedin
Find trials that include:  Any drugs shown
Results 1-5 of 5 for your search:
Start Over
A Phase II Clinical Trial of PM01183 in BRCA 1/2-Associated or Unselected Metastatic Breast Cancer
Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Age: 18 to 75
Trial IDs: PM1183-B-003-11, NCI-2014-00191, NCT01525589
Clinical Trial of Lurbinectedin (PM01183) in Selected Advanced Solid Tumors
Phase: Phase II
Type: Treatment
Age: 18 and over
Trial IDs: PM1183-B-005-14, NCI-2015-01172, NCT02454972
Study of PM01183 in Non-Colorectal Cancer Patients as a Days 1 and 8 Intravenous Short Infusion Every 3 Weeks
Phase: Phase I
Type: Biomarker/Laboratory analysis, Treatment
Age: 18 and over
Trial IDs: PM1183-A-005-11, NCI-2013-00690, NCT01405391
Evaluation of the Effect of Lurbinectedin (PM01183) on Cardiac Repolarization in Patients With Selected Solid Tumors
Phase: Phase I
Type: Biomarker/Laboratory analysis, Supportive care
Age: 65 and under
Trial IDs: PM1183-B-005-14-QT, NCI-2015-01174, NCT02451007
Start Over